Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Skeeter Bug who wrote (30017)	1/9/2000 6:29:00 PM
From: Torben Noerup Nielsen	Respond to of 32384

Skeeter, mentioning the FDA and accountability in the same sentence is problematic. As far as I can tell, they're the Supreme Court for these things and there's really no recourse if they turn something down. Irrespective of why they might be doing it. However, ABC patient groups can be rather vocal and they've got more clout than a lot of groups do. If there's a drug that could help them, the FDA could easily end up facing a great deal of political pressure to move and move quickly. In this case, we don't have a problem with the FDA any longer though. The drug is approved and if the test results support it's usage, it will be used. We're really just waiting for the Fat Lady to take inhale and.... Thanks, Torben